Thermo Fisher Scientific Inc. (TMO) Return on Invested Capital (ROIC): 7.58%
Is Thermo Fisher Scientific Inc.’s return on invested capital (ROIC) high or low?
Thermo Fisher Scientific Inc.'s return on invested capital (ROIC) of 7.58% is 17% below its 5-year average of 9.10%, near the low end of its 5-year range (7.58%–11.32%).
As of Thursday, June 11, 2026. 2.88% below its 12-month average of 7.80%.
TMO Return on Invested Capital (ROIC) Chart
TMO Average Return on Invested Capital (ROIC) Chart
TMO Current vs Average Return on Invested Capital (ROIC) Chart
TMO Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
7.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
7.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
7.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
6.63%
CURRENT VS TTM AVG
-2.88%
CURRENT VS 3Y AVG
-7.08%
CURRENT VS 5Y AVG
-16.75%
CURRENT VS 10Y AVG
-4.97%
CURRENT VS 15Y AVG
+4.11%
CURRENT VS 20Y AVG
+14.36%
TMO Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $176.21B | 7.58% | 7.80% | 8.16% | 9.10% |
| Amgen Inc. (AMGN) | $188.37B | 13.16% | 11.04% | 11.80% | 12.80% |
| Gilead Sciences, Inc. (GILD) | $156.35B | 21.53% | 11.95% | 11.58% | 9.92% |
| Abbott Laboratories (ABT) | $155.75B | 8.43% | 9.16% | 9.70% | 9.86% |
| Pfizer Inc. (PFE) | $149.61B | 8.84% | 9.06% | 10.60% | 10.43% |
| Intuitive Surgical, Inc. (ISRG) | $144.79B | 13.71% | 12.85% | 12.25% | 11.92% |
| CVS Health Corporation (CVS) | $126.70B | 4.72% | 4.17% | 4.46% | 4.93% |
| Danaher Corporation (DHR) | $126.39B | 5.72% | 5.90% | 6.54% | 6.70% |
| Bristol-Myers Squibb Company (BMY) | $116.13B | 13.90% | 13.75% | 11.92% | 10.17% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.59B | 18.12% | 10.38% | 14.75% | 17.51% |
Capital Efficiency
ROIC
7.6%
ROE
13.2%
Thermo Fisher Scientific Inc. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Thermo Fisher Scientific Inc. (TMO)?
- The return on invested capital (ROIC) for TMO stock is 7.58%.
- Is Thermo Fisher Scientific Inc.'s return on invested capital (ROIC) high or low?
- Thermo Fisher Scientific Inc.'s return on invested capital (ROIC) of 7.58% is 17% below its 5-year average of 9.10%, near the low end of its 5-year range (7.58%–11.32%).
- What is the TTM average return on invested capital (ROIC) for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average return on invested capital (ROIC) for TMO stock is 7.80%.
- What is the 3Y average return on invested capital (ROIC) for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average return on invested capital (ROIC) for TMO stock is 8.16%.
- What is the 5Y average return on invested capital (ROIC) for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average return on invested capital (ROIC) for TMO stock is 9.10%.
- What is the 10Y average return on invested capital (ROIC) for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average return on invested capital (ROIC) for TMO stock is 7.98%.
- What is the 15Y average return on invested capital (ROIC) for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average return on invested capital (ROIC) for TMO stock is 7.28%.
- What is the 20Y average return on invested capital (ROIC) for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average return on invested capital (ROIC) for TMO stock is 6.63%.
Thermo Fisher Scientific Inc. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 7.58% |
| 2024-12-31 | 8.03% |
| 2023-12-31 | 8.02% |
| 2022-12-31 | 9.00% |
| 2021-12-31 | 10.68% |
| 2020-12-31 | 11.32% |
| 2019-12-31 | 7.29% |
| 2018-12-31 | 6.79% |
| 2017-12-31 | 5.79% |
| 2016-12-31 | 6.63% |
| 2015-12-31 | 6.61% |
| 2014-12-31 | 5.37% |
| 2013-12-31 | 5.87% |
| 2012-12-31 | 6.35% |
| 2011-12-31 | 5.35% |
| 2010-12-31 | 5.81% |
| 2009-12-31 | 5.08% |
| 2008-12-31 | 5.56% |
| 2007-12-31 | 4.85% |
| 2006-12-31 | 1.53% |
| 2005-12-31 | 5.68% |
| 2004-12-31 | 7.11% |
| 2003-12-31 | 5.31% |
| 2002-12-31 | 3.48% |
| 2001-12-31 | 0.69% |
| 2000-12-31 | 1.67% |
| 1999-12-31 | -4.64% |
| 1998-12-31 | 3.61% |
| 1997-12-31 | 4.82% |
| 1996-12-31 | 4.10% |
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper